Guaifenesin
- Product NDC
- 69848-018
- 11-digit product format
- 698480018
- Labeler code
- 69848
- Product ID
- 69848-018_469099a1-3de3-d107-e063-6294a90adf16
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- GRANULES USA, INC.
- Application
- ANDA213420
- Marketing category
- ANDA
- Marketing start
- 2024-09-12
- Substance
- GUAIFENESIN
- Active strength
- 1200 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Guaifenesin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GUAIFENESIN | 1200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 495W7451VQ |
| Rxcui | 310621 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69848-018-16 | Guaifenesin | 14 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 14 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69848-018 | GUAIFENESIN TABLET, EXTENDED RELEASE [GRANULES USA, INC.] | 6 | Current NDC, Legacy NDC, 1 package rows | 20241228_a62e2045-8ec2-1771-e053-2995a90a03b4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69848-018-16 | 69848001816 | 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (69848-018-16) | 2024-09-12 | 0000-00-00 | No | No | Current |